Anne Wagner: Combining Cognitive Behavioral Conjoint Therapy for PTSD and MDMA

Cognitive Behavioral Conjoint Therapy for PTSD combined with MDMA is a current pilot study investigating treatment effectiveness. The approach adapts a 15 session, 3-phase behavioral protocol for couples in which one partner has a PTSD diagnosis. Recent trial evidence underscores the value of non-directive supportive psychotherapy alongside MDMA, and the integration of these two formats aims to leverage the potential additive and augmenting effects of behavioral therapy modules for participants struggling with post-traumatic stress disorders. Careful attention is paid to the timing, set, and setting within these sessions to support meaningful connection and communication between partners. Initial case data suggests patients and their partners report improved relationship satisfaction and reduced symptoms following this combined treatment structure.